Antipsychotics

A study of deficiency-of-care citations in nursing homes offers lessons on reducing over-reliance on psychotropics in residents with dementia, investigators say.

The findings raise questions about the short- and long-term effects on the quality of care and health outcomes for residents, the authors say.

A federal study has found that prescriptions for antipsychotic medication in nursing homes and assisted living facilities increased by 7.4% during the first quarter, or first three months, of the pandemic. 

Informed consent is not consistently interpreted in regards to the use of drugs such as antipsychotics in nursing home residents with dementia. 

President Biden’s State of the Union address last week targeted several aspects of the long-term care industry, most of which have received more attention than his mention of reducing the inappropriate...

The use of antipsychotics and pain medications in assisted living and nursing home residents was relatively unchanged early in the pandemic. New residents were more likely to get certain drugs, however.

Antipsychotics are associated with a higher risk of death in older adults with dementia, with none of the excess risk due to the drugs’ interactions with cardiovascular comorbidities or diabetes,...

Has the COVID-19 pandemic had a devastating impact on staffing and occupancy for senior living communities? It certainly has. In the face of these daunting obstacles, do we need to lean into supportive...

The increased odds of experiencing a stroke within 60 days of starting treatment suggests that even short-term antipsychotic use should be avoided if possible, investigators contend.

Reducing antipsychotic medication use in long-term care residents has been a focus for both nursing home operators and practitioners for nearly 10 years since the launch of the Center for Medicare & Medicaid...